Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Azenta Inc. is a premier provider of sample management solutions and life science tools, dedicated to enhancing laboratory efficiencies within the biotechnology and pharmaceutical industries. The company excels in innovative automation and comprehensive biorepository services, facilitating faster drug discovery while ensuring adherence to stringent regulatory standards. With a forward-looking strategy that leverages advanced storage technologies and strategic partnerships, Azenta is uniquely positioned to seize growth opportunities in the expanding global life sciences market. Its commitment to pioneering scientific research through sophisticated innovations underscores its potential appeal to institutional investors seeking exposure in the dynamic life sciences sector.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$34.02
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 4, 2026 | $0.10 | $0.16 | Beat +60.0% | $0.05 | — | $161.18M | — | 1D Pre+6.2% | On-Day+0.8% | 1D Post+5.6% |
Q ended Mar 31, 2026 Reported May 6, 2026 | $0.14 | $-0.04 | Miss -128.6% | $-3.49 | — | $144.79M | — | 1D Pre+1.2% | On-Day-25.3% | 1D Post+1.0% |
Q ended Dec 31, 2025 Reported Feb 4, 2026 | $0.13 | $0.09 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| Miss -30.8% |
| — |
| — |
| $148.64M |
| — |
| 1D Pre-1.7% |
| On-Day-22.8% |
| 1D Post-2.2% |
Q ended Sep 30, 2025 Reported Nov 21, 2025 | $0.20 | $0.21 | Beat +5.0% | — | — | $159.19M | — | 1D Pre-0.1% | On-Day+16.3% | 1D Post+5.2% |